E Miller, N Andrews, P Waight… - Clinical and Vaccine …, 2011 - Am Soc Microbiol The coadministration of the combined meningococcal serogroup C conjugate (MCC)/Haemophilus influenzae type b (Hib) vaccine with pneumococcal conjugate vaccine (PCV7) and measles, mumps, and rubella (MMR) vaccine at 12 months of age was investigated to assess the ... Related articles - All 4 versions
PA Rota, KE Brown, JM Hübschen… - Journal of Infectious …, 2011 - jid.oxfordjournals.org An important aspect of laboratory surveillance for measles and rubella is the genetic characterization of circulating wild-type viruses to support molecular epidemiologic studies and to track transmission pathways. Virologic surveillance that is sufficient to document the interruption of ... Cited by 1 - Related articles - All 3 versions
DA Featherstone, PA Rota… - Journal of Infectious …, 2011 - jid.oxfordjournals.org Enhancing measles surveillance with integration of epidemiologic and laboratory information is one of the key strategies for accelerated measles control and elimination. The World Health Organization (WHO) Global Measles and Rubella Laboratory Network (LabNet) has been ... Cited by 1 - Related articles - All 3 versions
SE Reef, P Strebel, A Dabbagh… - Journal of Infectious …, 2011 - jid.oxfordjournals.org Rubella, usually a mild rash illness in children and adults, can cause serious consequences when a pregnant woman is infected, particularly in early pregnancy. These serious consequences include miscarriage, fetal death or an infant born with birth defects (ie, congenital rubella ... Related articles - All 4 versions
JL Goodson, B Masresha, A Dosseh… - Journal of Infectious …, 2011 - jid.oxfordjournals.org Rubella is vaccine-preventable; the primary objective of rubella-control programs is prevention of congenital rubella virus infection, which includes CRS. Rubella is among the small number of viral diseases considered to be potentially eradicable [4, 5]. Rubella can be eliminated ... Related articles - All 3 versions